Search - tctmd.com

Displaying 741 - 760 of 3664

Sort: Relevancy | Date

Presentation TCT 2022

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

Presenter: Sayonara Daal

September 19, 2022

Presentation TCT 2022

TCT 602: Comparison of Bleeding and Vascular Complications With Single Versus Double Proglide Vascular Closure After Transcatheter Aortic Valve Replacement

Presenter: Alan Zajarias

September 19, 2022

Presentation TCT 2022

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Presenter: Yeonwoo Choi

September 19, 2022

Presentation TCT 2022

TCT 601: Comparision of the Safety and Effectiveness of Suture-Based Versus Plug-Based for Large-Bore Access Closure.

Presenter: Igor Vaz

September 19, 2022

Presentation TCT 2022

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

Presenter: Keith Allen

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

$TCT 764: An uncrossable lesion of ostial flash chronic total occlusion in right coronary artery in heart failure with reduced ejection fraction: debulking atherectomy successfully performed to triple vessel disease.$

Presentation TCT 2022

TCT 764: An uncrossable lesion of ostial flash chronic total occlusion in right coronary artery in heart failure with reduced ejection fraction: debulking atherectomy successfully performed to triple vessel disease.

Presenter: Toru NAKANISHI

September 18, 2022

Presentation TCT 2022

CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

Presenter: Helge Möllmann

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 803: Aortic Stenosis with Left Main disease and Porcelain Aorta – Thrill of Victory

Presenter: Rahul Gupta

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

AI-Based Algorithm for Determination of Clinically Significant Coronary Disease Using a 12-Lead ECG (Heartio)

Presenter: Michael Leasure

September 17, 2022

Presentation TCT 2022

Case-Based Presentation: MINOCA – Current Evidence on Prognosis and Treatment

Presenter: Jacqueline Tamis-Holland

September 17, 2022

Presentation TCT 2022

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

Presenter: Ahmed Altibi

September 17, 2022

Presentation TCT 2022

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

Presenter: Toishi Sharma

September 17, 2022

Presentation TCT 2022

Keynote Speech: Diagnosis and Treatment of CAD in Women – The Role of Social Determinant of Health

Presenter: Clyde Yancy

September 17, 2022

Presentation TCT 2022

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

Presenter: David Wood

September 17, 2022

Presentation TCT 2022

Case #3: Symptomatic Microvascular Disease

Presenter: Nils Johnson

September 17, 2022

Presentation TCT 2022

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Presenter: Arnold Seto

September 17, 2022

Advertisement

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

TCT 602: Comparison of Bleeding and Vascular Complications With Single Versus Double Proglide Vascular Closure After Transcatheter Aortic Valve Replacement

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

TCT 601: Comparision of the Safety and Effectiveness of Suture-Based Versus Plug-Based for Large-Bore Access Closure.

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

TCT 764: An uncrossable lesion of ostial flash chronic total occlusion in right coronary artery in heart failure with reduced ejection fraction: debulking atherectomy successfully performed to triple vessel disease.

CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 803: Aortic Stenosis with Left Main disease and Porcelain Aorta – Thrill of Victory

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

AI-Based Algorithm for Determination of Clinically Significant Coronary Disease Using a 12-Lead ECG (Heartio)

Case-Based Presentation: MINOCA – Current Evidence on Prognosis and Treatment

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

Keynote Speech: Diagnosis and Treatment of CAD in Women – The Role of Social Determinant of Health

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

Case #3: Symptomatic Microvascular Disease

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content